EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment

Cemre Boşnak iD, Gökhan Metan iD, Pınar Zarakolu, Elifcan Aladağ Karakulak, Aslı Pınar, Hakan Göker, Jason A Roberts, Maria Patricia Hernandez-Mitre iD, Murat Akova

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Cemre Boşnak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Levofloxacin, Anti-Bacterial Agents, Antibiotic Prophylaxis, Neutropenia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hacettepe University Scientific Research Projects Coordination Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the clinical and microbiological factors associated with the failure of levofloxacin prophylaxis in high-risk haematology patients, with a particular focus on the attainment of the pharmacokinetic/pharmacodynamic (PK/PD) target.

Methods

This prospective case–control study evaluated adult high-risk haematology patients receiving levofloxacin prophylaxis (750 mg/day) during neutropenia. Analyses were performed at the episode level. Individual levofloxacin exposure was described using a population PK model, with the PK/PD target defined as fAUC0–24/MIC ≥80. Surveillance cultures were used to characterize Gram-negative bacterial (GNB) colonization and resistance profiles.

Results

A total of 120 neutropenic episodes were analysed. Profound neutropenia was independently associated with prophylaxis failure (OR: 4.17; 95% CI: 1.70–10.2; P = 0.002], whereas achievement of fAUC/MIC ≥80 was independently associated with a reduced risk of failure (OR: 0.12; 95% CI: 0.02–0.62; P = 0.012). Receiver operating characteristic curve analysis identified fAUC/MIC ≥48.46 as the Youden-optimal cutoff (sensitivity 86.0%, specificity 38.3%; Youden J = 0.243). Achievement of this cutoff was also independently associated with a reduced risk of prophylaxis failure (OR: 0.26; 95% CI: 0.083–0.803; P = 0.019). Target non-attainment was strongly associated with levofloxacin-resistant GNB colonization, indicating that PK/PD failure was predominantly MIC driven.

Conclusions

Levofloxacin prophylaxis failure appears to reflect an interplay between host factors and inadequate PK/PD target attainment, which was largely influenced by levofloxacin-resistant GNB colonization. The standard 750 mg dose was insufficient in a significant proportion of patients, supporting the need for prophylaxis strategies that integrate PK/PD targets and local resistance patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinAnti-Bacterial AgentsAntibiotic ProphylaxisNeutropeniaGram-Negative Bacterial InfectionsHumansProspective StudiesFemaleMaleTreatment FailureCase-Control StudiesMicrobial Sensitivity TestsMiddle AgedAgedAdultGram-Negative BacteriaDrug Resistance, Bacterial

Substanzen

LevofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of Hematology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of Biochemistry, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Frazer Institute, Faculty of Medicine, Health, and Behavioral Sciences, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Intensive Care Medicine and Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Australia.

ORCID-Profile: Cemre Boşnak, Gökhan Metan, Maria Patricia Hernandez-Mitre

Förderung

  • Hacettepe University Scientific Research Projects Coordination Unit

Zitieren

APA

Boşnak, C., Metan, G., Zarakolu, P., Karakulak, E. A., Pınar, A., Göker, H., Roberts, J. A., Hernandez-Mitre, M. P., & Akova, M. (2026). Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag284

Vancouver

Boşnak C, Metan G, Zarakolu P, Karakulak EA, Pınar A, Göker H, et al. Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag284

BibTeX
@article{Bonak2026,
  author = {Boşnak, Cemre and Metan, Gökhan and Zarakolu, Pınar and Karakulak, Elifcan Aladağ and Pınar, Aslı and Göker, Hakan and Roberts, Jason A and Hernandez-Mitre, Maria Patricia and Akova, Murat},
  title = {Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag284}
}
Kostenlos starten →